載入...
Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens
Despite recent progress in the development of new molecularly targeted agents, the chemotherapy regimens considered standard at the end of the last century—that is, two-drug combinations consisting of either cisplatin or carboplatin plus a third-generation agent (docetaxel, paclitaxel, gemcitabine,...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AlphaMed Press
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227896/ https://ncbi.nlm.nih.gov/pubmed/20930102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0322 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|